These meds work by mimicking a gut hormone (GLP-1) that signals fullness, slows stomach emptying, and manages blood sugar originally developed for type 2 diabetes
Tests include: Occasionally, your provider may perform a liver biopsy
TRIUMPH-2 confirmed up to 20.8% weight loss and -1.6 percentage points HbA1c reduction in 1,152 patients with obesity and type 2 diabetes (July 23, 2026)
References China National Medical Products Administration
Anaesthetists are very experienced in managing patients with reduced gastric emptying
Agilent, he adds, is also exploring circular economy models and green lab certifications to further reduce environmental impact, ensuring that innovation goes together with responsibility. With India rapidly evolving as a biopharma manufacturing hub, Kalathil points out that the country is well-positioned to support global supply chains for GLP-1 therapies. Capacity, challenges and collaboration For manufacturers, the biggest challenge is the rising demand for GLP-1 therapies with sufficient device capacity